Multi-drug Resistant Tuberculosis (MDR-TB) and Extensively Drug Resistant Tuberculosis (XDR)
USAID World Health Organization Adult Drug-Resistant TB ... - StopTB GDF...Adult Drug-Resistant TB...
26
Medicines WHO Guidelines (DR-TB '19) WHO Guidelines (DR-TB '20) EML submitted EML (2019) WHO PQ EOI (2021) WHO PQ Dossier Under Review WHO PQ listed Global Fund List of Pharmaceutical Products Global Fund ERP EOI (Nov 2020) Global Fund ERP approved GDF Catalog Amikacin 1000mg vial Amikacin 100mg vial Amikacin 500mg/2mL vial Amoxicillin/clavulanate 500mg/125mg tablet Bedaquiline 100mg tablet Clofazimine 100mg tablet/capsule Clofazimine 50mg tablet/capsule Adult Drug-Resistant TB Medicines Dashboard This Dashboard has been developed by Stop TB Partnership/Global Drug Facility in collaboration with USAID, the World Health Organization and The Global Fund to fight AIDS, TB & Malaria. Stop TB Partnership/Global Drug Facility licensed the TB Medicines Dashboard under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Status Yes No Rejected Ineligible for inclusion N/A DR-TB: Drug-Resistant TB EML: Essential Medicines List EOI: Expression of Interest ERP: Expert Review Panel SRA: Stringent Regulatory Authority WHO PQ: World Health Organization Prequalification of Medicines Programme Updated version July 2021
Transcript of USAID World Health Organization Adult Drug-Resistant TB ... - StopTB GDF...Adult Drug-Resistant TB...
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Amikacin1000mgvial
Amikacin100mgvial
Amikacin500mg/2mLvial
Amoxicillin/clavulanate500mg/125mgtablet
Bedaquiline100mgtablet
Clofazimine100mgtablet/capsule
Clofazimine50mgtablet/capsule
Cycloserine250mgcapsule
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Clofazimine50mgtablet/capsule
Cycloserine250mgcapsule
Delamanid50mgtablet
Ethambutol400mgtablet/capsule
Ethionamide250mgtablet/capsule
Gatifloxacin200mgtablet
Gatifloxacin400mgtablet
Imipenem/cilastatin250/250mgvial
Imipenem/cilastatin500/500mgvial
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Imipenem/cilastatin250/250mgvial
Imipenem/cilastatin500/500mgvial
Imipenem/cilastatin/clavulanate500/500/125mgvial
Isoniazid300mgtablet/capsule
Levofloxacin250mgtablet/capsule
Levofloxacin500mgtablet/capsule
Levofloxacin750mgtablet/capsule
Linezolid400mgtablet
Linezolid600mgtablet
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Linezolid400mgtablet
Linezolid600mgtablet
Linezolidinjection2mg/mLin300mLbag
Meropenem1000mgvial
Meropenem500mgvial
Meropenem/clavulanate1000mg/125mgvial
Moxifloxacin400mgtablet/capsule
PAS4gmgranules
PAS500mgtablet
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
PAS4gmgranules
PAS500mgtablet
PASSodium100gmpowder
PASSodium4gm/5.52gmpowder
PASSodium4gm/9.2gmpowder
Pretomanid200mgtablet
Protionamide250mgtablet/capsule
Pyrazinamide150mgtabletscored
Pyrazinamide400mgtablet/capsule
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB'19)
WHOGuidelines
(DR-TB'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossierUnder
Review
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Pyrazinamide150mgtabletscored
Pyrazinamide400mgtablet/capsule
Pyrazinamide500mgtablet/capsule
Streptomycin1000mgvial
Terizidone250mgtablet/capsule
Terizidone500mgtablet
AdultDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoRejectedIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
WHOGuidelines
(LTB
I'18)
WHOGuidelines
(LTB
I'20)
Ethambutol400mgtablet/capsule
Ethambutol/Isoniazid/Pyrazinamide/Rifampicin275/75/400/150mgtablet/capsule
Ethambutol/Isoniazid/Rifampicin275/75/150mgtablet/capsule
Isoniazid100mgtablet
Isoniazid300mgtablet/capsule
Isoniazid/Pyrazinamide/Rifampicin75/400/150mgtablet/capsule
Isoniazid/Rifampicin75/150mgtablet/capsule
Isoniazid/Rifampicin150/300mgtablet/capsule
Moxifloxacin100mgdispersibletablet
Moxifloxacin400mgtablet/capsule
AdultDrug-SensitiveTBDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
WHOGuidelines
(LTB
I'18)
WHOGuidelines
(LTB
I'20)
Moxifloxacin100mgdispersibletablet
Moxifloxacin400mgtablet/capsule
Pyrazinamide400mgtablet/capsule
Pyrazinamide500mgtablet/capsule
Rifabutin150mgcapsule
Rifampicin150mgcapsule
Rifampicin300mgcapsule
Rifapentine150mgtablet
Rifapentine300mg
Rifapentine/Isoniazid300mg/300mgtablet
AdultDrug-SensitiveTBDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(LTBI'18)
WHOGuidelines
(LTBI'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Isoniazid300mgtablet/capsule
Isoniazid/Rifampicin75/150mgtablet/capsule
Isoniazid/Rifampicin150/300mgtablet/capsule
Rifampicin150mgcapsule
Rifampicin300mgcapsule
Rifapentine150mgtablet
Rifapentine300mg
Rifapentine/Isoniazid300mg/300mgtablet
Sulfamethoxazole/Trimethoprim/Isoniazid/Pyridoxine 800/160/300/25mg tablet
AdultLatentTBInfectionDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
LTBI:LatentTBInfectionEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(LTBI'18)
WHOGuidelines
(LTBI'20)
EMLsubm
itted
EML(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERPEOI
(Nov2020)
GlobalFundERP
approved
GDFCatalog
Rifapentine/Isoniazid 300mg/300mgtabletSulfamethoxazole/Trimethoprim/Isoniazid/Pyridoxine800/160/300/25mgtablet
AdultLatentTBInfectionDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
LTBI:LatentTBInfectionEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Amikacin100mgvial
Amikacin500mg/2mLvial
Amikacin1000mgvial
Amoxicillin/clavulanate500mg/125mgtablet
Amoxicillin/clavulanicacid125mg/31.25mg/5mLoralsuspension
Amoxicillin/clavulanicacid250mg/62.5mg/5mLoralsuspension
Bedaquiline20mgtablet
Bedaquiline100mgtablet
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Bedaquiline20mgtablet
Bedaquiline100mgtablet
Clofazimine50mgtablet/capsule
Cycloserine125mgcapsule
Delamanid25mgdispersibletablet
Delamanid50mgdispersibletablet
Delamanid50mgtablet
Ethambutol25mg/mLoralliquid
Ethambutol50mgdispersibletablet
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Ethambutol25mg/mLoralliquid
Ethambutol50mgdispersibletablet
Ethambutol100mgdispersibletablet
Ethambutol100mgtablet
Ethionamide125mgdispersibletablet
Ethionamide125mgtablet/capsule
Isoniazid50mgdispersibletablet
Isoniazid50mgtabletscored
Isoniazid50mg/5mLoralliquid
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Isoniazid50mgtabletscored
Isoniazid50mg/5mLoralliquid
Isoniazid100mgdispersibletablet
Isoniazid100mgtablet
Isoniazid300mgtablet/capsule
Levofloxacin100mgdispersibletablet
Linezolid20mg/mLoralsuspension
Linezolid150mgdispersibletablet
Linezolid400mgtablet
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Linezolid 150mg dispersibletablet
Linezolid400mgtablet
Linezolid600mgtablet
Linezolidinjection2mg/mLin300mLbag
Meropenem500mgvial
Meropenem1000mgvial
Meropenem/clavulanate1000mg/125mgvial
Moxifloxacin100mgdispersibletablet
Moxifloxacin400mgtablet/capsule
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Moxifloxacin 100mg dispersibletablet
Moxifloxacin400mgtablet/capsule
PAS4gmgranules
PAS500mgtablet
PASSodium4gm/5.52gmpowder
PASSodium4gm/9.2gmpowder
PASSodium100gmpowder
Pretomanid200mgtablet
Pyrazinamide30mg/mLoralliquid
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
WHOGuidelines
(DR-TB
'19)
WHOGuidelines
(DR-TB
'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Pretomanid200mgtablet
Pyrazinamide30mg/mLoralliquid
Pyrazinamide150mgdispersibletablet
Pyrazinamide150mgtabletscored
Streptomycin1000mgvial
PediatricDrug-ResistantTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DR-TB:Drug-ResistantTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Ethambutol25mg/mLoralliquid
Ethambutol50mgdispersibletablet
Ethambutol100mgdispersibletablet
Ethambutol100mgtablet
Isoniazid50mgdispersibletablet
Isoniazid50mgtabletscored
Isoniazid50mg/5mLoralliquid
Isoniazid100mgdispersibletablet
Isoniazid100mgtablet
PediatricDrug-SensitiveTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Isoniazid 100mg dispersibletablet
Isoniazid100mgtablet
Isoniazid300mgtablet/capsule
Moxifloxacin100mgdispersibletablet
Moxifloxacin400mgtablet/capsule
Pyrazinamide30mg/mLoralliquid
Pyrazinamide150mgdispersibletablet
Pyrazinamide150mgtabletscored
Rifampicin20mg/mLoralliquid
Rifampicin/Isoniazid75/50dispersible tablet
PediatricDrug-SensitiveTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(DS-TB
'17)
WHORapid
Communication
(DS-TB
'21)
EMLcsubmitted
EMLc(2019)
WHOPQEOI(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundER
PEO
I(Nov2020)
GlobalFundER
Papproved
GDFCatalog
Rifampicin20mg/mLoralliquid
Rifampicin/Isoniazid75/50dispersibletablet
Rifampicin/Isoniazid/Pyrazinamide75/50/150mgdispersibletablet
Rifapentine150mgdispersibletablet
Rifapentine150mgtablet
Rifapentine300mg
Rifapentine/Isoniazid300mg/300mgtablet
PediatricDrug-SensitiveTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
DS-TB:Drug-SensitiveTBEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(LTBI'18)
WHOGuidelines
(LTBI'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI
(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundList
ofPharmaceutical
Products
GlobalFundERP
EOI(Nov2020)
GlobalFundERP
approved
GDFCatalog
Isoniazid50mgdispersibletablet
Isoniazid50mgtabletscored
Isoniazid50mg/5mLoralliquid
Isoniazid100mgdispersibletablet
Isoniazid100mgtablet
Isoniazid300mgtablet/capsule
Levofloxacin100mgdispersibletablet
Rifampicin20mg/mLoralliquid
Rifampicin/Isoniazid75/50dispersible tablet
PediatricLatentTBInfectionMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
LTBI:LatentTBInfectionEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines WHOGuidelines
(LTBI'18)
WHOGuidelines
(LTBI'20)
EMLcsubmitted
EMLc(2019)
WHOPQEOI
(2021)
WHOPQDossier
UnderReview
WHOPQlisted
GlobalFundList
ofPharmaceutical
Products
GlobalFundERP
EOI(Nov2020)
GlobalFundERP
approved
GDFCatalog
Rifampicin20mg/mLoralliquid
Rifampicin/Isoniazid75/50dispersibletablet
Rifapentine150mgdispersibletablet
Rifapentine300mg
Sulfamethoxazole/Trimethoprim/Isoniazid/Pyridoxine400/80/150/12.5mgtablet
PediatricLatentTBInfectionMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionN/A
LTBI:LatentTBInfectionEML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
EML
EMLc
WHOPQEOI
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERP
approved
GDFCatalog
Amoxicillin/clavulanate875mg/125mgtablet
Bedaquiline100mgdispersabletablet
Capreomycin500mgvial
Capreomycin750mgvial
Capreomycin1000mgvial
Ethambutol200mgtablet/capsule
Ethambutol275mgtablet/capsule
Ethambutol1000mgvial
Ethambutol2000mgvial
FormulationsnolongerrecomendedTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionRejectedRemoved
EML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
EML
EMLc
WHOPQEOI
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERP
approved
GDFCatalog
Ethambutol1000mgvial
Ethambutol2000mgvial
Ethambutol/Isoniazid400/150mgtablet/capsule
Isoniazid100mg/5mLoralliquid
Isoniazid100mg/mLvial
Isoniazid/Pyrazinamide/Rifampicin150/500/150mgtablet/capsule
Isoniazid/Rifampicin150/150mgtablet/capsule
Kanamycin500mgvial
Kanamycin1000mgvial
PASInjection
FormulationsnolongerrecomendedTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionRejectedRemoved
EML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
EML
EMLc
WHOPQEOI
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERP
approved
GDFCatalog
Kanamycin1000mgvial
PASInjection
Pyrazinamide250mgtablet/capsule
Rifampicin450mgtablet
Rifampicin600mgvial
Rifapentine300mgscored,dispersible
Rifapentine/Isoniazid150mg/150mgdispersibletablet
Rifapentine/Isoniazid300mg/300mgdispersibletablet
Streptomycin750mgvial
Terizidone300mgtablet/capsule
FormulationsnolongerrecomendedTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionRejectedRemoved
EML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
Medicines
EML
EMLc
WHOPQEOI
WHOPQlisted
GlobalFundListof
Pharmaceutical
Products
GlobalFundERP
approved
GDFCatalog
Streptomycin750mgvial
Terizidone300mgtablet/capsule
FormulationsnolongerrecomendedTBMedicinesDashboardThisDashboardhasbeendevelopedbyStopTBPartnership/GlobalDrugFacilityincollaborationwithUSAID,the WorldHealthOrganizationandTheGlobalFundtofightAIDS,TB&Malaria.StopTBPartnership/GlobalDrugFacilitylicensedtheTBMedicinesDashboardundera CreativeCommonsAttribution-NonCommercial-ShareAlike4.0InternationalLicense.
StatusYesNoIneligibleforinclusionRejectedRemoved
EML:EssentialMedicinesListEOI:ExpressionofInterestERP:ExpertReviewPanelSRA:StringentRegulatoryAuthorityWHOPQ:WorldHealthOrganizationPrequalificationofMedicinesProgramme
Updated version July 2021
